⌘K
Loading ticker…
Lixte Biotechnology Holdings, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Lixte Biotechnology Holdings, Inc. Common Stock (LIXT) has a 3-month relative strength percentile of 98 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 97. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 12.0%, relative volume 0.53×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 98, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
LIXT appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $152K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $152K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LIXT Jan avg: 15.23% median: 8.18% win: 50% σ: 30.18% n: 4 2022-04-12 → 2026-05-29 | LIXT Feb avg: -7.75% median: -3.72% win: 50% σ: 33.11% n: 4 2022-04-12 → 2026-05-29 | LIXT Mar avg: 5.12% median: -0.35% win: 50% σ: 17.89% n: 4 2022-04-12 → 2026-05-29 | LIXT Apr avg: -5.02% median: 4.13% win: 60% σ: 19.45% n: 5 2022-04-12 → 2026-05-29 | LIXT May avg: 8.65% median: -7.14% win: 40% σ: 44.61% n: 5 2022-04-12 → 2026-05-29 | LIXT Jun avg: -9.30% median: -7.96% win: 25% σ: 11.52% n: 4 2022-04-12 → 2026-05-29 (current) | LIXT Jul avg: 72.67% median: -3.93% win: 50% σ: 178.20% n: 4 2022-04-12 → 2026-05-29 | LIXT Aug avg: -7.65% median: -6.93% win: 50% σ: 18.86% n: 4 2022-04-12 → 2026-05-29 | LIXT Sep avg: -3.07% median: 1.43% win: 50% σ: 17.86% n: 4 2022-04-12 → 2026-05-29 | LIXT Oct avg: -2.94% median: -4.95% win: 50% σ: 12.41% n: 4 2022-04-12 → 2026-05-29 | LIXT Nov avg: 13.12% median: 2.61% win: 50% σ: 26.95% n: 4 2022-04-12 → 2026-05-29 | LIXT Dec avg: -12.39% median: -8.47% win: 25% σ: 14.73% n: 4 2022-04-12 → 2026-05-29 |